Form 4: Kezar Life Sciences SVP Sells Shares to Cover Tax Obligations

Kezar Life Sciences' SVP, Corporate Controller, Pichi Luo Chiang, sold 264 shares of common stock at $4.28 per share to satisfy tax withholding obligations related to restricted stock unit vesting.

Summary

• Pichi Luo Chiang, SVP, Corporate Controller of Kezar Life Sciences, Inc. (KZR), disposed of 264 shares of common stock.
• The transaction occurred on July 2, 2025, at a price of $4.28 per share.
• The sale was non-discretionary and executed to cover statutory tax withholding obligations associated with the vesting of restricted stock units, as mandated by the company's equity incentive plans.
• Following this transaction, the reporting person beneficially owns 2,711 shares of common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary 'sell to cover' for tax purposes, which is neutral in terms of company sentiment. It does not indicate positive or negative sentiment regarding the company's performance or outlook.

Future Outlook

NA

Industry Context

This transaction is a routine insider filing (Form 4) common across all industries, particularly for companies with equity compensation plans. It reflects a standard mechanism for employees to cover tax liabilities upon the vesting of restricted stock units, rather than an event tied to specific industry trends or competitive dynamics.

Stakeholder Impact

• Shareholders: Minimal direct impact as it's a small, non-discretionary sale for tax purposes, not indicative of insider sentiment.
• Employees: Reflects the standard operation of the company's equity compensation plan, which is a common benefit.

Key Dates

Keywords

Kezar Life Sciences, KZR, Form 4, Insider Transaction, Stock Sale, Restricted Stock Units, Tax Withholding, Equity Incentive Plan, Corporate Controller